Mineralys Therapeutics, Inc.
MLYS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $597,515 | $311,217 | $95,279 | $91,905 |
| - Cash | $114,091 | $49,304 | $87,701 | $10,612 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $483,424 | $261,913 | $7,578 | $81,293 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$192,360 | -$84,657 | -$31,479 | -$19,381 |
| % Margin | – | – | – | – |
| Net Income | -$177,810 | -$71,898 | -$29,799 | -$19,408 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.66 | -1.99 | -5.77 | -3.89 |
| % Growth | -83.9% | 65.5% | -48.3% | – |
| Operating Cash Flow | -$166,314 | -$81,173 | -$29,221 | -$14,559 |
| Capital Expenditures | -$96 | $0 | $0 | $0 |
| Free Cash Flow | -$166,410 | -$81,173 | -$29,221 | -$14,559 |